Position in MDGL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,147
+$54 QoQ
Shares Held
4
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#391
of 411 holders
Holding Since
Jun 2024
9 quarters on record
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Park Place Capital Corp holds $841,864 across 23 Biotechnology names. MDGL ranks #11 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
676 | $335,789 | |
| 2 | RPRX |
Royalty Pharma plc
|
3,510 | $196,805 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
328 | $98,737 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
1,433 | $81,996 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
594 | $46,492 | |
| 6 | TECH |
BIO-TECHNE Corp
|
468 | $33,064 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
94 | $22,651 | |
| 8 | ARGX |
Argenx SE
|
6 | $5,566 |
All Filings in MDGL
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,147 | 4 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,093 | 4 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $2,329 | 4 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $1,834 | 4 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $1,210 | 4 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $1,324 | 4 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $1,234 | 4 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $848 | 4 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $1,120 | 4 | Shares | Sole | 2024-07-02 | |
| No filing history on record for this holder in this stock. | ||||||